| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/07/2008 | WO2008093464A1 Animal having modification in mgat2 gene |
| 08/07/2008 | WO2008093356A1 Pharmaceutical composition for treatment of diabetic complications |
| 08/07/2008 | WO2008092891A1 1-oxa-3-azaspiro(4.5)decan-2-one derivatives for the treatment of eating disorders |
| 08/07/2008 | WO2008092888A1 1-oxa-3-azaspiro[4,5]decan--2-one derivatives for the treatment of eating disorders |
| 08/07/2008 | WO2008092887A1 I-oxa-3-azaspiro (4.5) decan-2-one and 1-oxa-3, 8-diazaspiro (4.5) decan-2-one derivatives for the treatment of eating disorders |
| 08/07/2008 | WO2008092816A2 Novel polymorphic forms of n-piperidino-5-(4-chlorophenyl)-1(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamide |
| 08/07/2008 | WO2008092785A1 Novel 2-aminooxazolines as taar1 ligands for cns disorders |
| 08/07/2008 | WO2008092681A1 Ghrelin receptor modulators |
| 08/07/2008 | WO2008092666A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
| 08/07/2008 | WO2008092665A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
| 08/07/2008 | WO2008092591A2 Use of guanidinoacetic acid (salts) combined with betaine and/or choline for producing a health-promoting agent |
| 08/07/2008 | WO2008092327A1 Half-hydrated crystal of voglibose, the preparation thereof and pharmaceutical composition containing the same |
| 08/07/2008 | WO2008092231A1 Compounds for the prevention and treatment of cardiovascular diseases |
| 08/07/2008 | WO2008092199A1 Thiopyrimidine-based compounds and uses thereof |
| 08/07/2008 | WO2007143002A3 Nutraceutical treatments for diabetic and non-diabetic wound healing |
| 08/07/2008 | WO2007140222A3 Pyrrolopyrimidine compounds and their uses |
| 08/07/2008 | WO2007126935A3 Diazepan orexin receptor antagonists |
| 08/07/2008 | WO2007120936A3 Use.of vildagliptin for the treatment of diabetes |
| 08/07/2008 | WO2007068116A8 Method for correcting a lipid imbalance in a subject |
| 08/07/2008 | US20080188654 Compounds for treatment of inflammation, diabetes and related disorders |
| 08/07/2008 | US20080188549 A specific edible compound derived from a naturally occurring substance such as licorice; a peroxisome proliferator activated receptors gamma ligand agent; flavonoids; anticholesterol agents;antilipemic agents; hypoglycemic agents; antidiabetic agents |
| 08/07/2008 | US20080188548 Cyclic ether vitamin D3 compounds, 1alpha(OH)3-epi-vitamin D3 compounds and uses thereof |
| 08/07/2008 | US20080188539 Ramipril-amino acid salts |
| 08/07/2008 | US20080188538 Administering rampiril; dysglycemia, where the patient has no history of cardiovascular disease |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/07/2008 | US20080188519 Novel azacyclic ethynyl derivatives |
| 08/07/2008 | US20080188507 3-(3-biphenylyl)-5-[3-oxospiro[6-azaisobenzofuran-1(3H),4'-piperidin]-1'-yl]-1H-pyrazole; neuropeptide Y receptor antagonists; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 08/07/2008 | US20080188501 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 08/07/2008 | US20080188488 Heterocyclic Derivatives and Their Use as Stearoyl-Coa Desaturase Inhibitors |
| 08/07/2008 | US20080188486 e.g. (1-cyclopentylmethyl-1H-indol-5-yl)-(4-isopropyl-piperazin-1-yl)-methanone; antagonists and/or inverse agonists at the histamine 3 receptor; antidepressant, anxiolytic agent; obesity, cardiovascular disorders |
| 08/07/2008 | US20080188476 Comprises zonisamide (anticonvulsant) in combination with bupropion for enhancing activity of norepinephrine and/or dopamine via uptake inhibition; side effect reduction |
| 08/07/2008 | US20080188472 Indole-2-Carboxylic Acid Hydrazides |
| 08/07/2008 | US20080188471 Dipeptidyl Peptidase-IV Inhibiting Compounds, Method Of Preparing The Same, And Pharmaceutical Compositions Containing The Same As An Active Agent |
| 08/07/2008 | US20080188447 Glucocorticoid-lowering composition |
| 08/07/2008 | US20080188444 Improved lipophilicity, toxicity, bioavailability, and pharmacokinetics; for treatment of cardiovascular and neurological disorders; alzheimer's disease |
| 08/07/2008 | US20080188426 Sodium dependent glucose transporter inhibition; hyperglycemia associated diseases; 3-glucopyranosyloxy- 1H-indazole and 1H-pyrazolo[3,4-b]pyridine derivatives |
| 08/07/2008 | US20080188422 Peptides having separate domains; AIDS, cardiovascular disease, hepatitis. diabetes, cancer; side effect reduction |
| 08/07/2008 | US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 08/07/2008 | US20080188406 Methods and reagents for treating glucose metabolic disorders |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | US20080187622 Method for manufacturing alpha-glycosylisoquercitrin, intermediate product and by-product thereof |
| 08/07/2008 | US20080187540 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 08/07/2008 | US20080187525 Nutrient capsule which enhances in vivo propagation of bifidobacterium and lactobacillus probiotics |
| 08/07/2008 | US20080187522 Enhancing a population of insulin releasing cells using gfr-a1 agonists |
| 08/07/2008 | DE102007005045A1 New phenothiazine derivative for use in preparing medicine for blood sugar lowering and for treatment of diabetes, nicotine dependence, alcohol dependence, central nervous system disorders, schizophrenia, and Alzheimer's disease |
| 08/07/2008 | DE102007004781A1 Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels The use of guanidinoacetic acid (salts) for the preparation of a beneficial agent |
| 08/07/2008 | CA2702647A1 Thiopyrimidine-based compounds and uses thereof |
| 08/07/2008 | CA2680843A1 Pharmaceutical composition for treatment of diabetic complications |
| 08/07/2008 | CA2676984A1 Compounds for the prevention and treatment of cardiovascular diseases |
| 08/07/2008 | CA2676977A1 Use of chromium histidinate for treatment of cardiometabolic disorders |
| 08/07/2008 | CA2675996A1 Atorvastatin strontium salt and pharmaceutical composition comprising same |
| 08/07/2008 | CA2675468A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
| 08/07/2008 | CA2675466A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
| 08/07/2008 | CA2675450A1 Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders |
| 08/07/2008 | CA2675221A1 Novel 2-aminooxazolines as taar1 ligands |
| 08/06/2008 | EP1953172A1 TRUNCATED GLUCAGON-LIKE PEPTIDE-1 (sGLP-1) AND ITS PREPARING METHOD AND USE |
| 08/06/2008 | EP1953165A1 Aza-substituted spiro derivative |
| 08/06/2008 | EP1953162A1 Xanthin derivatives, their production and utilisation as medicine |
| 08/06/2008 | EP1953153A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
| 08/06/2008 | EP1953144A1 Novel polymorphic forms of N-piperidino-5-(4-chlorophenyl)-1-(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamide |
| 08/06/2008 | EP1953141A1 Aryl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
| 08/06/2008 | EP1953140A1 Process for the preparation of ezetimibe and derivatives thereof |
| 08/06/2008 | EP1953136A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same |
| 08/06/2008 | EP1952817A1 Aloe vera extract, process for production of aloe vera extract, and ameliorating agent for hyperglycemia |
| 08/06/2008 | EP1952815A1 The use of ginkgo biloba extract in preparation of a composition for lowering cholesterol |
| 08/06/2008 | EP1952814A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 08/06/2008 | EP1951755A2 Anti-myostatin antibodies |
| 08/06/2008 | EP1951731A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 08/06/2008 | EP1951725A1 N-sulfamoyl-n -benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 08/06/2008 | EP1951707A1 Substituted pyrrolones as allosteric modulators of glucokinase |
| 08/06/2008 | EP1951706A1 Dihydroisoindolones as allosteric modulators of glucokinase |
| 08/06/2008 | EP1951692A1 Oxazole and thiazole ppar modulator |
| 08/06/2008 | EP1951690A1 Heterocyclic cetp inhibitors |
| 08/06/2008 | EP1951688A1 A novel compound, useful for pancreatic lipase inhibition and the process for isolation thereof |
| 08/06/2008 | EP1951673A2 Heterocyclic cetp inhibitors |
| 08/06/2008 | EP1951669A1 Acyl indoles, compositions containing such compounds and methods of use |
| 08/06/2008 | EP1951659A2 Glucagon receptor antagonists, preparation and therapeutic uses |
| 08/06/2008 | EP1951658A1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 08/06/2008 | EP1951315A2 Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors |
| 08/06/2008 | EP1951289A2 Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity) |
| 08/06/2008 | EP1951286A1 Combined use of dpp iv inhibitors and gastrin compounds |
| 08/06/2008 | EP1951275A1 Antiobesity composition |
| 08/06/2008 | EP1951224A2 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 08/06/2008 | EP1951220A2 Compositions for lowering serum cholesterol and/or triglycerides |
| 08/06/2008 | EP1951212A2 Compositions and methods for increasing insulin sensitivity |
| 08/06/2008 | EP1951048A2 Flavanols and b-type procyanidins and inflammation |
| 08/06/2008 | EP1773768A4 Pyrrole derivatives as pharmaceutical agents |
| 08/06/2008 | EP1664344B1 Method of diagnosis of obesity |
| 08/06/2008 | EP1557465B1 Cap-binding protein |
| 08/06/2008 | EP1532113B1 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 08/06/2008 | EP1485088B1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 08/06/2008 | EP1397341B1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 08/06/2008 | EP1385518B1 Benzimidazolone compounds |
| 08/06/2008 | EP1377277B1 Pharmaceutical compositions comprising pravastatin for reducing ldl cholesterol levels |
| 08/06/2008 | EP1366059B1 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 08/06/2008 | EP1328515B1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 08/06/2008 | EP1311475B1 Aminocyclohexane derivatives |
| 08/06/2008 | EP1257298B1 Cosmid dna constructs and methods of making and using the same |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1173757B1 Diagnosis of human kidney diseases |